About 28 000 reports

China’s demand for Diagnostic Reagent has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...

  • Clinical Diagnostic
  • China
  • Industrial Production
  • Labour Force

The global sepsis diagnostics market is projected to reach US$ 1,226.52 million by 2028 from US$ 661.83 million in 2021; it is expected to grow at a CAGR of 9.2% from 2021 to 2028. Factors such as the rising incidence of sepsis due to increasing nosocomial infections and growing demand for rapid diagnostic tests leading to increasing...

  • Diagnostics
  • Blood Disease
  • World
  • APAC
  • Diagnostic Revenue
  • Mortality Rate

Influenza Diagnostics Global Market Opportunities And Strategies To 2031 provides the strategists; marketers and senior management with the critical information they need to assess the global influenza diagnostics market as it emerges from the COVID-19 shut down. Description: Where is the largest and fastest growing...

  • Diagnostics
  • Influenza
  • World
  • Health Expenditure
  • Gross Domestic Product

The Europe sepsis diagnostics market is expected to grow from US$ 193.12 million in 2021 to US$ 360.55 million by 2028; it is estimated to grow at a CAGR of 9.3% from 2021 to 2028. Technology is a critical parameter in healthcare diagnostics to provide accuracy and save time and resources.In the sepsis diagnosis process, identifying...

  • Diagnostics
  • Blood Disease
  • Europe
  • Diagnostic Revenue
  • Health Expenditure

The APAC sepsis diagnostics market is expected to grow from US$ 131.79 million in 2021 to US$ 249.70 million by 2028; it is estimated to grow at a CAGR of 9.6% from 2021 to 2028. The rising need for rapid diagnostics for sepsis fueled the research activities among key players in recent years.Both the existing players and the start-ups...

  • Diagnostics
  • Blood Disease
  • APAC
  • Diagnostic Revenue
  • Mortality Rate

The diagnostic labs market is projected to grow from US$ 297.06 billion in 2021 to US$ 514.28 billion by 2028; it is expected to grow at a CAGR of 8.3% from 2022 to 2028. The increasing prevalence of chronic diseases, increasing use of point-of-care diagnostics, and rising healthcare expenditures bolster the growth of the diagnostic...

  • Diagnostics
  • World
  • APAC
  • Medical Technology Density
  • Health Expenditure

The MEA sepsis diagnostics market is expected to grow from US$ 19.20 million in 2021 to US$ 33.35 million by 2028; it is estimated to grow at a CAGR of 8.2% from 2021 to 2028. Technology is a critical parameter in healthcare diagnostics to provide accuracy and save time and resources.In the process of sepsis diagnosis, identification...

  • Diagnostics
  • Blood Disease
  • World
  • Middle East
  • Africa
  • Saudi Arabia
  • South Africa
  • United Arab Emirates
  • Diagnostic Revenue
  • Health Expenditure

The South America sepsis diagnostics market is expected to grow from US$ 38.66 million in 2021 to US$ 69.59 million by 2028; it is estimated to grow at a CAGR of 8.8% from 2021 to 2028. Infection is the root cause of sepsis.Sepsis mainly occurs in immunocompromised people, such as those taking chemotherapy, having a splenectomy, and...

  • Diagnostics
  • Blood Disease
  • Brazil
  • Argentina
  • Diagnostic Revenue
  • Mortality Rate

The sepsis diagnostics market was valued at USD 550 million in 2020 and is expected to reach USD 975 million in 2026 by registering the CAGR of 9.8% during the forecast period. The coronavirus disease 2019 has proved to wreak havoc to health system leaders throughout the world. The healthcare systems across the world are witnessing...

  • Blood Disease
  • Diagnostics
  • World
  • Health Expenditure
  • Mortality Rate

The North America sepsis diagnostics market is expected to grow from US$ 279.06 million in 2021 to US$ 513.33 million by 2028; it is estimated to grow at a CAGR of 9.1% from 2021 to 2028. Sepsis diagnosis requires laboratory skills and proficiency to process the collection and investigation of the clinical sample.Sepsis is a life-threatening...

  • Diagnostics
  • Blood Disease
  • North America
  • Diagnostic Revenue
  • Mortality Rate

China’s demand for Cancer Diagnostics has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...

  • Cancer Diagnostics
  • China
  • Industrial Production
  • Labour Force

The global molecular diagnostics market is projected to reach USD 30.2 billion by 2027 from USD 23.2 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as the increasing use of PoC diagnostic tests, the rising funding for R&D in molecular diagnostics, the increasing prevalence of infectious...

  • Molecular Diagnostics
  • World
  • North America
  • Health Expenditure
  • Cancer Incidence

The global precision diagnostics market is expected to grow from US$ 79,776.88 million in 2022 to US$ 1,68,405.71 million by 2028; it is expected to grow at a CAGR of 13.3% from 2022 to 2028. Factors such as the increasing demand for precision diagnostics and rising application in oncology and other disorders drive the growth of the...

  • Diagnostics
  • World
  • Diagnostic Revenue
  • Cancer Incidence

China’s demand for Diagnostic Medical Equipment has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer...

  • Medical Equipment
  • Diagnostics
  • China
  • Medical Devices Sales
  • Medical Technology Density

The global Tissue Diagnostics market is growing at a CAGR of 6.6% during and it is expected to reach USD 7.3 billion by 2027 from USD 5.3 billion in 2022, during the forecast period. The expansion of this market is majorly due to rising prevalence of neoplastic cases as well as high demand of oncology screening, However, Lack of skilled professionals...

  • Diagnostics
  • World
  • Europe
  • North America
  • APAC
  • Cancer Incidence
  • Health Expenditure

The global blood transfusion diagnostics market is expected to grow from US$ 4,096.93 million in 2021 to US$ 6,483.75 million by 2028. It is estimated to grow at a CAGR of 6.9% from 2022 to 2028. The report highlights prevailing trends and factors driving the market growth. The growth of the global blood transfusion diagnostics market...

  • Blood Transfusion
  • Diagnostics
  • World
  • APAC
  • Diagnostic Revenue
  • Surgical Procedures Performed

The Brazil diagnostic labs market is projected to reach US$ 24,334.07 million by 2028 from US$ 13,367.60 million in 2022; it is expected to grow at a CAGR of 10.5% from 2022 to 2028. Rising prevalence of ageing-related diseases and chronic diseases drives the overall market growth. Use of Artificial Intelligence (AI) and analytics in...

  • Diagnostics
  • Brazil
  • Health Expenditure
  • Medical Technology Density

The global autoimmune disease diagnostics market was valued around US$ 14 Billion in 2021. Autoimmune diseases refer to a body’s abnormal immune response leading to production of antibodies that attack own cells and tissues, causing deterioration and destruction of healthy tissues. There are almost 80 types of autoimmune diseases prevailing...

  • Autoimmune Disease
  • Diagnostics
  • World
  • Health Expenditure
  • Auto-Immune Diseases Prevalence

The infectious disease diagnostics market is expected to grow from US$ 23,890 million in 2021 to US$ 37,943.90 million by 2028; it is estimated to grow at a CAGR of 6.8% from 2021 to 2028. The report highlights trends prevailing in the market and factors driving the infectious disease diagnostics market growth. The market growth is attributed...

  • Infectious Disease
  • Diagnostics
  • World
  • APAC
  • Europe
  • Diagnostic Revenue
  • Health Expenditure

The global sepsis diagnostics market size is expected to reach USD 771 million by 2026 from USD 503 million in 2021, at a CAGR of 8.9%. The demand is expected to grow due to the rising incidence of sepsis, a growing number of surgical procedures, high incidence of hospital-acquired infections, and increasing availability of a wide variety...

  • Diagnostics
  • Blood Disease
  • World
  • United States
  • North America
  • Europe
  • APAC
  • Surgical Procedures Performed
  • Mortality Rate

The Liver cancer diagnostics market size is projected to reach US$ US$ 15,951.77 million by 2028 from US$ 9,323.14 million in 2021; it is estimated to grow at a CAGR of 8.0% during 2021–2028. The report highlights the key factors driving the market and prominent players with their developments.The growth of the liver cancer diagnostics...

  • Liver Cancer
  • Diagnostics
  • World
  • APAC
  • Europe
  • Middle East
  • Health Expenditure
  • Mortality Rate

The Infectious Disease Diagnostics Market was estimated to be USD 38,480.89 million in 2021 and is poised to grow at a CAGR of 3.79% by 2027 to reach USD 50,345.74 million. The COVID-19 pandemic has significantly impacted the infectious disease diagnostics market. Increasing incidences of infection in COVID-19 patients is anticipated...

  • Infectious Disease
  • Diagnostics
  • World
  • Health Expenditure
  • HIV AIDS Prevalence

Special Coagulation Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update Summary Medical Devices sector report, “Special Coagulation Tests Pipeline Report including Stages of Development, Segments, Region and Countries,...

  • Coagulation Diagnostic
  • World
  • Drug Approval
  • Medical Devices Sales

The global infectious disease diagnostics market size is projected to reach USD 33.1 billion by 2027 from USD 35.5 billion in 2022, at a -1.4% CAGR.Market is driven by factors such as indication of infectious diseases, growing trend in POC testing and rising technological advancements. However,an unfavorable reimbursement scenario is expected...

  • Infectious Disease
  • Diagnostics
  • World
  • APAC
  • Health Expenditure
  • Disposable Income

The Asia Pacific prostate cancer nuclear medicine market is expected to grow from US$ 156.10 million in 2022 to US$ 295.37 million by 2028; it is estimated to grow at a CAGR of 11.2% from 2022 to 2028. Nuclear medicine is mostly used to diagnose cardiovascular disease and cancer.Since the nuclear medicine industry is saturated, many...

  • Prostate Cancer
  • Diagnostics
  • APAC
  • Diagnostic Revenue
  • Diagnostic Imaging Density

The global companion diagnostics market is projected to reach USD 9.9 billion by 2026 from USD 5.5 billion in 2021, at a CAGR of 12.6% during the forecast period. Market growth is driven by factors such as the growing significance of companion diagnostics in drug development and rising incidence of cancer and growing adoption of targeted therapies. "The...

  • Diagnostics
  • World
  • United States
  • Europe
  • North America
  • APAC
  • Cancer Incidence
  • Health Expenditure

The women’s health diagnostics market is expected to register a CAGR of 7.5% over the forecast period. During the pandemic, limited transportation and travel restrictions created impediments for international trade and transportation, which disrupted the supply chains for the women’s health diagnostics market, temporarily leading to...

  • Diagnostics
  • Dietary Supplement
  • World
  • Health Expenditure
  • Cervical Cancer Screening Coverage

China’s demand for Patient Monitoring and Diagnostic Systems has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import...

  • Patient Monitoring
  • Diagnostics
  • China
  • Industrial Production
  • Labour Force

The global prostate cancer nuclear medicine diagnostics market is expected to grow from US$ 720.12 million in 2022 to US$ 1,315.66 million by 2028. It is estimated to grow at a CAGR of 10.6% from 2022 to 2028. Prostate cancer affects the prostate glands in males.Prostate cancer is common cancer following skin cancer in males. Common...

  • Prostate Cancer
  • Diagnostics
  • World
  • Diagnostic Revenue
  • Health Expenditure

The global point-of-care molecular diagnostics market size is projected to reach USD 4.1 billion by 2026 from USD 2.8 billion in 2021, at a CAGR of 8.2% during the forecast period. Market growth is driven by factors such as the increasing prevalence of infectious diseases and cancer, rising focus on decentralized diagnostics and increasing...

  • Molecular Diagnostics
  • World
  • Health Expenditure
  • Disposable Income